Marvellon Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.70 Cr
- Satisfied Charges ₹ 8.00 M
- Revenue Growth %
- Profit Growth 129.84%
- Ebitda 366.27%
- Net Worth 23.58%
- Total Assets 150.69%
About Marvellon Pharmaceuticals
Marvellon Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 April 2019 (Five years and ten months 15 days old ). Its registered office is in Panchkula, Haryana, India.
The Corporate was formerly known as Vvpb Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹1.70 Cr. The company has closed loans amounting to ₹8.00 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Kumar and Anil Kumar serve as directors at the Company.
Company Details
-
Location
Panchkula, Haryana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24100HR2019PTC079580
-
Company No.
079580
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Apr 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Marvellon Pharmaceuticals Private Limited offer?
Marvellon Pharmaceuticals Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, Common Disease Medicines, Allopathic Cough Syrup, Chemical Reagents & Catalysts, Ammonium Compound, Pain Relief Drugs & Pharmaceuticals, Aceclofenac.
Who are the key members and board of directors at Marvellon Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Kumar
|
Director | 27-Oct-2020 | Current |
|
Anil Kumar
|
Director | 27-Oct-2020 | Current |
Financial Performance of Marvellon Pharmaceuticals.
Marvellon Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 129.84% increase in profit. The company's net worth Soared by an impressive increase of 23.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Marvellon Pharmaceuticals?
In 2022, Marvellon Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹16.96 M
₹8.00 M
Charges Breakdown by Lending Institutions
- Canara Bank : 1.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Jul 2022 | Canara Bank | ₹1.70 Cr | Open |
| 13 Dec 2019 | Others | ₹8.00 M | Satisfied |
How Many Employees Work at Marvellon Pharmaceuticals?
Unlock and access historical data on people associated with Marvellon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Marvellon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Marvellon Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
